Antiaritmik (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antiaritmik" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

4^th place

8^th place

6^th place

9^th place

719^th place

152^nd place

2^nd place

5^th place

archive.org

Unless else specified in boxes, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.
Kulmatycki KM; Abouchehade K; Sattari S; Jamali F (Maj 2001). »Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat«. Br. J. Pharmacol. 133 (2): 286–94. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.

doi.org

Kulmatycki KM; Abouchehade K; Sattari S; Jamali F (Maj 2001). »Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat«. Br. J. Pharmacol. 133 (2): 286–94. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.

medscape.com

emedicine.medscape.com

http://emedicine.medscape.com/article/2172024-overview, vpogled: 24. 7. 2015.

nih.gov

ncbi.nlm.nih.gov

Singh BN, Vaughan Williams EM (1970). "The effect of amiodarone, a new anti-anginal drug, on cardiac muscle". Br. J. Pharmacol. 39 (4): 657–67. doi:10.1111/j.1476-5381.1970.tb09891.x. PMC 1702721. PMID 5485142.
Kulmatycki KM; Abouchehade K; Sattari S; Jamali F (Maj 2001). »Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat«. Br. J. Pharmacol. 133 (2): 286–94. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.

pubmed.ncbi.nlm.nih.gov

Kulmatycki KM; Abouchehade K; Sattari S; Jamali F (Maj 2001). »Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat«. Br. J. Pharmacol. 133 (2): 286–94. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.